Post-Brachytherapy Initial Tumour Regression Rate Correlates With Metastatic Spread in Posterior Uveal Melanoma

British Journal of Ophthalmology - United Kingdom
doi 10.1136/bjo.2003.036285
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Head and Neck: Posterior Uveal Melanoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Nestin Expression in Primary and Metastatic Uveal Melanoma - Possible Biomarker for High-Risk Uveal Melanoma

Acta Ophthalmologica
MedicineOphthalmology
2018English

Ischemia Is Related to Tumour Genetics in Uveal Melanoma

Cancers
Cancer ResearchOncology
2019English

Endoresection With Adjuvant Ruthenium Brachytherapy for Selected Uveal Melanoma Patients - The Tuebingen Experience

Acta Ophthalmologica
MedicineOphthalmology
2016English

Head and Neck: Posterior Uveal Melanoma - An Update

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2008English

Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2005English

Ruthenium-106 Brachytherapy in Treatment of Uveal Melanoma: 50 Years of Use!

BIO Web of Conferences
2019English

Safety of Pars Plana Vitrectomy in Eyes With Plaque-Irradiated Posterior Uveal Melanoma

Archives of Ophthalmology
2012English

iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma Tumors

PLoS ONE
Multidisciplinary
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy